NCT06113653 is a clinical trial of Prospective study in Neonatal Sepsis, sponsored by Assiut University.

Who is sponsoring NCT06113653?

NCT06113653 is sponsored by Assiut University.

What drugs are being tested in NCT06113653?

Interventions in NCT06113653: Prospective study.

What condition does NCT06113653 study?

NCT06113653 studies Neonatal Sepsis.

Is NCT06113653 still recruiting?

NCT06113653 is currently status unknown. Last updated 2 November 2023.

Last reviewed 2023-11-02 · How we verify

NCT06113653

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Outcomes and Predictors of Mortality Among Preterm Infants With Neonatal Sepsis

Status unknown Last updated 2 November 2023

What this trial tests

trial testing Prospective study in Neonatal Sepsis in 50 participants. Status unknown.

Timeline

28 October 2023

Primary endpoint
31 December 2024

31 March 2025

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	50
Start date	28 October 2023
Primary completion	31 December 2024
Estimated completion	31 March 2025

Drugs / interventions tested

Prospective study

Conditions studied

Neonatal Sepsis — all drugs for Neonatal Sepsis →

Sponsor

Assiut University

Who can join

Adults 1 Minute to 28 Days, any sex, with Neonatal Sepsis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A prospective cross-sectional study of outcomes and predictors of mortality among preterm infants with neonatal sepsis admitted in NICU of Assiut University Children's Hospital

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Prospective study

Trials testing the same drug.

NCT03331952 — A Study of Streptococcus Pneumonia Colonisation and Invasive Disease in Cambodian Children · completed

Other recruiting trials for Neonatal Sepsis

Currently open trials in the same condition.

NCT07421323 — Chlorhexidine Gluconate and Alcohol Hand Rubbing on Healthcare-associated Infection · NA · recruiting
NCT06592586 — A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women · Phase 2, PHASE3 · active not recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06113653 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 2 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06113653.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing